spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  COLLEAGUE 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 4 Feb 2026
Stratus Medical Raises $10 million Series B to Complete Development of New Technology and Fund Clinical Trial
Devices Venture Capital
 HSMN NewsFeed - 16 Oct 2025
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2025
Abbott's Navitor(TM) TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Aug 2025
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Devices FDA
 HSMN NewsFeed - 24 Jun 2025
Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 8 Apr 2025
Brainomix Advances Stroke Care with Landmark FDA Clearance
Devices Neurology FDA
 HSMN NewsFeed - 5 Mar 2025
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2025
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2024
Tackling the ACL Tear Epidemic in Youth Athletes: A Promising Solution from Arthrex
Devices Orthopaedic
 HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 10 Sep 2024
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.(R) Therapy
Devices Wound Care Product Launch
 HSMN NewsFeed - 9 Sep 2024
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2024
Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2024
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
Devices Distribution
 HSMN NewsFeed - 11 Jul 2024
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo(R) (vadadustat) Tablets
Biopharmaceuticals
 HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 6 Jun 2024
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2024
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 27 Dec 2023
Lilly Completes Acquisition of POINT Biopharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2023
Ad Astra Diagnostics receives 510(k) clearance of QScout(TM) hematology analyzer, the first to report measures of infection and severity at point-of-care
Diagnostics FDA
 HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 22 Sep 2023
Abbott Completes Acquisition of Bigfoot Biomedical
Devices Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 31 Jul 2023
Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 18 Jul 2023
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2023
RayCare in clinical use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland
Devices Oncology
 HSMN NewsFeed - 5 Jul 2023
Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
Devices Cardiology FDA
 HSMN NewsFeed - 20 Jun 2023
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 19 May 2023
Abbott Receives FDA Approval for TactiFlex(TM) Ablation Catheter for Treatment of Abnormal Heart Rhythm
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 May 2023
HAPPE Spine Announces FDA Clearance for the INTEGRATE-C(TM) Interbody Fusion System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 3 May 2023
Convergent Therapeutics Announces $90 Million Series A Financing to Advance the Clinical Development of Radiopharmaceuticals for the Treatment of Prostate Cancer and Other Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Feb 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Devices Neurology FDA
 HSMN NewsFeed - 19 Dec 2022
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
Devices FDA Product Launch
 HSMN NewsFeed - 1 Nov 2022
Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 27 Oct 2022
Geistlich Pharma North America, Inc. Acquires Lynch Biologics, LLC, a Biologics and Tissue Engineering Company
Regenerative Medicine Surgery Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2022
3T Biosciences Debuts with $40 Million Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 22 Jul 2022
Published Studies Find Low Documented Adherence to Guideline-Based Care for Female Urinary Incontinence
Devices Urology
 HSMN NewsFeed - 31 May 2022
Abbott's FreeStyle Libre(R) 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 24 May 2022
Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 May 2022
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
Devices Urology Venture Capital
 HSMN NewsFeed - 4 May 2022
Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
Diagnostics FDA
 HSMN NewsFeed - 28 Apr 2022
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer(TM) Steerable Delivery Sheath for the Company's Amulet(TM) Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 31 Mar 2022
Alberto Mas Announces Intent to Retire from BD at End of Fiscal Year
Devices Personnel
 HSMN NewsFeed - 24 Mar 2022
Abbott's FreeStyle(R) Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin
Devices Monitoring Reimbursement
 HSMN NewsFeed - 2 Mar 2022
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 25 Feb 2022
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 21 Feb 2022
Abbott's CardioMEMS(TM) HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 18 Feb 2022
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2022
Prometheus Laboratories Announces the Launch of PredictrPK(TM) IFX, A Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel Disease
Diagnostics Gastroenterology Product Launch
 HSMN NewsFeed - 14 Feb 2022
Advanced Oxygen Therapy: Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
Devices Wound Care Personnel
 HSMN NewsFeed - 14 Feb 2022
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Feb 2022
Lumify Care Joins Forces with Medline to Expand Access to its Wearable Illumination Product Nationwide
Devices Distribution
 HSMN NewsFeed - 31 Jan 2022
Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany
Biopharmaceuticals
 HSMN NewsFeed - 12 Jan 2022
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 11 Jan 2022
ACELYRIN Appoints Melanie Gloria as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2022
Abbott's Proclaim(TM) XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.
Devices Neurology Radiology FDA
 HSMN NewsFeed - 9 Dec 2021
Johnson & Johnson Appoints Senior Leaders to Executive Committee
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2021
Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar referencing Prolia(R) and Xgeva(R)
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2021
Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 13 Oct 2021
Laborie Medical Technologies Acquires Pelvalon
Devices Mergers & Acquisitions
 HSMN NewsFeed - 1 Oct 2021
SpinaFX Medical announces Jeff Cambra as CEO
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 29 Sep 2021
Neurolens Names Mark Kremer Chief Revenue Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 Sep 2021
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2021
Protagonist Therapeutics Appoints Scott Plevy, M.D., Executive Vice President and Therapeutic Head, Gastroenterology
Biopharmaceutical Gastroenterology Personnel
 HSMN NewsFeed - 2 Sep 2021
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 2 Sep 2021
Elekta acquires Turkish distributor to strengthen market position
Devices Oncology Neurosurgery Distribution
 HSMN NewsFeed - 26 Aug 2021
FDA Clears Thermo Scientific EliA SmD(P)-S Test For Use In U.S.
Diagnostics FDA
 HSMN NewsFeed - 16 Aug 2021
Abbott's Amplatzer(TM) Amulet(TM) Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 2 Aug 2021
Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 27 Jul 2021
BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
Devices Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 12 Jul 2021
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jun 2021
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 30 Jun 2021
DCN Dx Acquires IVD Vision, a Developer of Diagnostics Instruments and Software
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 14 Jun 2021
Jim Vasselli, M.D., Joins Aulos Bioscience as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Jun 2021
MindMed Announces Chief Executive Officer Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2021
Abbott Confirms Capacity to Support Expanded Use of HeartMate 3(TM) Heart Pump
Devices Cardiology
 HSMN NewsFeed - 17 May 2021
Abbott Receives CE Mark for Navitor(TM), the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 May 2021
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 29 Apr 2021
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
Devices
 HSMN NewsFeed - 19 Apr 2021
Neoss Announces Stability Data On Neoss ProActive(R) Edge Implant System
Devices Dental
 HSMN NewsFeed - 8 Apr 2021
Abbott Receives CE Mark Approval for Next-Generation TriClip(TM) Device, Offering New Innovations for Tricuspid Heart Valve Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Mar 2021
Lilly Announces Leadership Transitions in Manufacturing and Ethics and Compliance Organizations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 4 Mar 2021
ControlRad(R) Announces FDA Clearance for ControlRad Select
Devices Interventional FDA Distribution
 HSMN NewsFeed - 20 Jan 2021
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 14 Jan 2021
Abbott to Launch the NeuroSphere(TM) myPath(TM) Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Devices Neurology Monitoring Product Launch
 HSMN NewsFeed - 14 Dec 2020
Abbott Develops New Pedialyte(R) Hydration Solution to Help Support Immune Health
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory
 HSMN NewsFeed - 7 Oct 2020
Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement
Diagnostics Oncology
 HSMN NewsFeed - 25 Sep 2020
Study Reveals Blood-Based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-Symptomatic Patients
Diagnostics
 HSMN NewsFeed - 15 Sep 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2020
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 1 Sep 2020
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
Devices Monitoring Endocrinology Reimbursement
 HSMN NewsFeed - 19 Aug 2020
Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera(R)
Biopharmaceuticals Generics Neurology Product Launch
 HSMN NewsFeed - 13 Aug 2020
Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 4 Aug 2020
Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Jul 2020
Stratus(TM) Medical announces FDA 510k clearance for the Vesta(TM) RF Cannula to expand product portfolio and the first Vesta patient treatments in the United States
Devices FDA
 HSMN NewsFeed - 23 Jul 2020
Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Devices Neurology FDA
 HSMN NewsFeed - 23 Jul 2020
FDA Clears First Blood Test for Identifying a Novel Allergic Sensitization to Red Meat
Diagnostics FDA
 HSMN NewsFeed - 9 Jul 2020
MolecuLight Launches i:X(R) Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting
Devices Surgery Wound Care Product Launch
 HSMN NewsFeed - 7 Jul 2020
Caris Precision Oncology Alliance Welcomes Penn's Abramson Cancer Center
Diagnostics Oncology
 HSMN NewsFeed - 6 Jul 2020
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
Devices Cardiology FDA
 HSMN NewsFeed - 1 Jul 2020
Sumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger of Tolero and Boston Biomedical
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Jun 2020
EXUMA Biotech Adds H. Michael Shepard to Scientific Advisory Board and Steven R. Frank to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 1 Jun 2020
Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2020
Hikma receives FDA approval for its generic Vascepa(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 May 2020
Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 11 May 2020
Abbott Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity(TM) i System
Diagnostics FDA Product Launch
 HSMN NewsFeed - 4 May 2020
CytoSorbents Promotes Vincent J. Capponi to President
Devices Personnel
 HSMN NewsFeed - 17 Apr 2020
Hoth Therapeutics Announces Additions to its Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 9 Apr 2020
Abbott's TriClip(TM) Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Mar 2020
Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Feb 2020
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 26 Feb 2020
Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper Elected Chairman of the Board of Directors
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 19 Feb 2020
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Devices Monitoring Drug Delivery Endocrinology
 HSMN NewsFeed - 18 Feb 2020
Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
Devices Cardiology Regulatory Product Launch
 HSMN NewsFeed - 10 Feb 2020
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Feb 2020
Pharvaris Appoints Peng Lu, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2020
Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
Devices Cardiology FDA
 HSMN NewsFeed - 30 Jan 2020
Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Jan 2020
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Devices Neurology FDA
 HSMN NewsFeed - 17 Jan 2020
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 18 Dec 2019
Pfizer and Mylan Announce Two Future Viatris Board Members
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 13 Nov 2019
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2019
Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreonam And Avibactam) For Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Devices
 HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Sep 2019
Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2019
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 17 Sep 2019
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Devices Monitoring Endocrinology Reimbursement
 HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA
 HSMN NewsFeed - 30 Aug 2019
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Aug 2019
Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2019
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jul 2019
Allergan Voluntarily Recalls BIOCELL(R) Textured Breast Implants and Tissue Expanders
Devices Product Recall
 HSMN NewsFeed - 17 Jul 2019
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 11 Jul 2019
Abbott Announces FDA Approval of the Alinity(TM) s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
Diagnostics FDA
 HSMN NewsFeed - 24 Jun 2019
Allergan Receives FDA Clearance For CoolTone(TM) Device
Devices Dermatology FDA
 HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jun 2019
Pfizer to Acquire Array BioPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Jun 2019
Sobi Acquires Emapalumab and Related Assets
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 May 2019
FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device
Devices Neurology FDA
 HSMN NewsFeed - 6 May 2019
Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
Devices Monitoring Cardiology Product Launch
 HSMN NewsFeed - 2 May 2019
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
Diagnostics HIV/AIDS Regulatory
 HSMN NewsFeed - 29 Apr 2019
New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease
Diagnostics Cardiology
 HSMN NewsFeed - 24 Apr 2019
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019
Devices Oncology
 HSMN NewsFeed - 29 Mar 2019
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2019
Abbott Announces CE Mark for Alinity(TM) m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Diagnostics Regulatory
 HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Mar 2019
Onkos Surgical(R) Set to Deliver on Promise of Innovation with 7 New Products Scheduled to Launch in 2019
Devices Surgery Oncology Product Launch
 HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 14 Feb 2019
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Jan 2019
Actinium Pharmaceuticals Appoints Accomplished Industry Executive Cynthia Pussinen as Executive Vice President of Technical Operations and Supply Chain
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jan 2019
Olympus Corporation Promotes U.S.-Based Company Leaders to Global Roles
Devices Personnel
 HSMN NewsFeed - 5 Dec 2018
MiMedx Announces Organizational Realignment Program
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Dec 2018
TIGR(R)Matrix shows promising results when used for incisional hernia prevention in septic patients undergoing laparoscopy
Devices Surgery
 HSMN NewsFeed - 26 Nov 2018
Allergan Makes New Appointments to Finance Leadership Team
Biopharmaceuticals Ophthalmology Dermatology Personnel
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Oct 2018
Tris Pharma Announces Hiring of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Devices Dermatology FDA
 HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 29 Aug 2018
GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 24 Aug 2018
GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Aug 2018
Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard(R)
Diagnostics Oncology
 HSMN NewsFeed - 8 Aug 2018
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Biopharmaceuticals Ophthalmology Dermatology Personnel
 HSMN NewsFeed - 23 Jul 2018
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jul 2018
MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 20 Jun 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Jun 2018
Allergan Continues Active Board Refreshment Process
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2018
ImaginAb Reconstitutes Scientific Advisory Board
Biopharmaceuticals Oncology Radiology Personnel
 HSMN NewsFeed - 16 May 2018
Roivant Expands Senior Leadership with Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2018
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 4 May 2018
Varian Notes Receipt of Competing Bid by Sirtex
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2018
Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 11 Apr 2018
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
Biopharmaceuticals Oncology Drug Delivery Personnel
 HSMN NewsFeed - 11 Apr 2018
Macrophage Pharma Appoints Dr Michael Moore as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2018
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin(R)) For The Treatment Of Three Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Mar 2018
Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron(TM) 1Xi Minute Ventilation Monitor in Pediatric Patients
Devices FDA
 HSMN NewsFeed - 8 Mar 2018
Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Feb 2018
Gore to Debut GORE(TM) ImproJect(TM) Plunger for Sensitive Biologics in Pre-Filled Syringes
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jan 2018
UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2018
Nevro Receives FDA Approval for Senza II(TM) Spinal Cord Stimulation System Delivering HF10(TM) Therapy
Devices FDA
 HSMN NewsFeed - 8 Jan 2018
Perrigo Appoints Uwe Röhrhoff As President & Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2018
Taiho Oncology Names Timothy Whitten President
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Dec 2017
PENTAX Medical Appoints Veteran Executive As The Americas Region President And CEO
Devices Gastroenterology Personnel
 HSMN NewsFeed - 18 Dec 2017
Neurotrope Appoints Charles S. Ryan as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 18 Dec 2017
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2017
Allergan Receives FDA Clearance For the CoolSculpting(R) Treatment To Improve Appearance Of Lax Tissue In The Double Chin
Devices Dermatology FDA
 HSMN NewsFeed - 29 Nov 2017
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Devices Personnel
 HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Oct 2017
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid(R)
Biopharmaceuticals Oncology Generics Licensing
 HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Sep 2017
CardioFocus(R) Announces European CE Mark Approval Of The Next-Generation HeartLight(R) Excalibur Balloon(TM) Designed For The Treatment Of Atrial Fibrillation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Sep 2017
Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Aug 2017
CSA Medical Announces Expansion of truFreeze(R) Label to Include Barrett's Esophagus with Low Grade Dysplasia
Devices Interventional FDA
 HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 31 Jul 2017
Amgen and Allergan Submit Biosimilar Biologics License Application for ABP 980 to US Food and Drug Administration
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Jul 2017
Enterin Inc. Raises $12.7 Million in Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Jun 2017
NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
Devices Oncology Radiology
 HSMN NewsFeed - 16 Jun 2017
Johnson & Johnson Announces Completion of Acquisition of Actelion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jun 2017
Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 May 2017
Drain-Free Mastectomy with TissuGlu(R) Surgical Adhesive Presented at UK Breast Surgery Meeting
Devices Surgery
 HSMN NewsFeed - 10 May 2017
Savara Announces Expedited U.S. Molgradex Development Strategy
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Apr 2017
Allergan Successfully Completes ZELTIQ(R) Aesthetics Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2017
Allergan Announces Advisory Role for Breast Implant Pioneer Hani Zeini
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2017
International Sonablate HIFU Prostate Registry Officially Launched
Devices Urology
 HSMN NewsFeed - 29 Mar 2017
Tepha Inc. Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE(TM) 3D Surgical Scaffold
Devices Surgery Product Launch
 HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch
 HSMN NewsFeed - 22 Mar 2017
BioStable Science & Engineering Announces FDA Clearance of the HAART(TM) 300 Aortic Annuloplasty Device
Devices Cardiology FDA
 HSMN NewsFeed - 22 Mar 2017
Allergan Announces Availability of RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 20 Mar 2017
JUVÉDERM VOLLURE(TM) XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21
Devices Dermatology FDA
 HSMN NewsFeed - 14 Mar 2017
Pfizer Launches Zavicefta(TM) (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2017
GS Medical USA Announces New Product Portfolio and Company Enhancements
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 6 Feb 2017
First U.S. Multi-center Investigational Clinical Trial of 177 Lu PSMA-617 Targeted Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer Receives FDA Clearance
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Feb 2017
Sanofi Appoints Hugo Fry as General Manager UK
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2017
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2017
Vtesse Announces Appointment of Jason Meyenburg as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2017
Alessandro Riva, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutic Area Head
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Dec 2016
Valeant Appoints William D. Humphries As EVP, Dermatology
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 5 Dec 2016
Mission Therapeutics Appoints Colin Goddard as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2016
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Devices Ophthalmology FDA
 HSMN NewsFeed - 10 Nov 2016
Allergan Announces Launch of TAYTULLA(TM) (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules) 1 mg/20 mcg, the First and Only Oral Contraceptive Softgel Capsule
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 10 Nov 2016
IBRANCE(R) (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Nov 2016
Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Oct 2016
Misonix Hands-On Lab Generates Strong Interest in BoneScalpel(R) at NASS
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 31 Oct 2016
European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Oct 2016
Allergan Introduces RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help Patients Produce More of Their Own Tears
Biopharmaceuticals Ophthalmology FDA Product Launch
 HSMN NewsFeed - 25 Oct 2016
Allergan Successfully Completes Vitae Tender Offer
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 19 Oct 2016
First Patient in Malaysia Receives TheraSphere(TM) Radioembolization Therapy
Devices Oncology
 HSMN NewsFeed - 17 Oct 2016
Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Oct 2016
Allergan plc Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to MEDI2070 Inflammatory Disorder Development Program
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 28 Sep 2016
Pfizer Completes Acquisition of Medivation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2016
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
Biopharmaceuticals Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Aug 2016
XALKORI(R) (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Aug 2016
Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 11 Aug 2016
Celldex Appoints Elizabeth Crowley as Chief Product Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Biopharmaceuticals Distribution Acquisitions
 HSMN NewsFeed - 27 Jul 2016
John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2016
TomoTherapy(R) System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 19 Jul 2016
TapImmune Appoints Dr. John N. Bonfiglio as President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jul 2016
Eagle Pharmaceuticals Announces Changes to Its Board of Directors; Director, Michael Graves Appointed Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jul 2016
Retina Implant AG Announces Change in Leadership
Devices Ophthalmology Personnel
 HSMN NewsFeed - 1 Jul 2016
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres(R) Y-90 resin microspheres, New SIRFLOX Analysis Shows
Devices Oncology
 HSMN NewsFeed - 28 Jun 2016
Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2016
Pfizer Completes Acquisition of Anacor
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Jun 2016
Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2016
Lightpoint Medical Announces Exclusive Global License Agreement With the University of Arizona to Develop Molecular Imaging Technology
Devices Radiology Licensing
 HSMN NewsFeed - 17 May 2016
Leeds St James Acquires Eight Elekta Linear Accelerators for Advanced Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 16 May 2016
Pfizer to Acquire Anacor
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2016
Alexza Pharmaceuticals to be Acquired by Ferrer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2016
Applied DNA Sciences Appoints Bob Miglani as Chief of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2016
Pliant Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2016
Accuray Hosts Regional AERO Users' Meeting
Devices Oncology
 HSMN NewsFeed - 18 Apr 2016
Elekta and Philips Begin Installation of MR-Guided Linear Accelerator at The Netherlands Cancer Institute
Devices Oncology Radiology
 HSMN NewsFeed - 8 Apr 2016
Eli Lilly and Company and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Apr 2016
Pfizer Announces Termination of Proposed Combination with Allergan
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Apr 2016
Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 30 Mar 2016
Biogen Appoints Michel Vounatsos Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2016
Heart Metabolics Announces Multiple Senior Appointments To Management Team
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 15 Mar 2016
Dutch Medical Center Begins Radiosurgery Treatments with Elekta's Leksell Gamma Knife Icon
Devices Oncology Neurosurgery
 HSMN NewsFeed - 14 Mar 2016
The European Association of Urology Upgrades UroLift(R) System Trial Data to its Highest Possible Classification - Level 1A - in its Guidelines
Devices Urology
 HSMN NewsFeed - 23 Feb 2016
SIRFLOX Study Published in Journal of Clinical Oncology
Devices Interventional Radiology Oncology
 HSMN NewsFeed - 4 Jan 2016
Padlock Therapeutics Creates West Coast Operations Appointing Scientific Co-founder Kerri Mowen, Ph.D., as Director of Biology Based in San Diego
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Nov 2015
Pfizer Receives European Approval to Expand Use of XALKORI(R) (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Nov 2015
Pfizer and Allergan to Combine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2015
Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI(R) (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Nov 2015
Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 12 Nov 2015
In New Study EMMA(TM) Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis
Devices Monitoring
 HSMN NewsFeed - 5 Nov 2015
Insys Therapeutics Announces Senior Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2015
Allergan Enters Into Licensing Agreement with Mimetogen Pharmaceuticals to Develop and Commercialize Tavilermide (MIM-D3) Topical Dry Eye Treatment
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 30 Oct 2015
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2015
Eli Lilly and Company Expands New York City Research and Development Site
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Sep 2015
Pfizer’s Sayana(R) Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 24 Aug 2015
Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2015
Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Aug 2015
Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Aug 2015
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jul 2015
Ophthotech Announces New Senior Leadership Appointments
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 1 Jul 2015
Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 May 2015
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2015
Gilead Sciences Acquires EpiTherapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2015
NeoGenomics Announces Promotions
Diagnostics Oncology Personnel
 HSMN NewsFeed - 16 Apr 2015
Sagent Pharmaceuticals Appoints Michael Logerfo as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2015
Tenax Therapeutics Provides Clinical and Corporate Update
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Mar 2015
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Feb 2015
Silk Road Medical Announces FDA 510(k) Clearance of the ENROUTE(R) Transcarotid Neuroprotection System
Devices Interventional FDA
 HSMN NewsFeed - 21 Jan 2015
Medivir Makes Change within the Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2015
Teleflex Reports Study Results of ARROWg+ard(R) Technology Effectiveness in Preventing Infections and Associated Costs in an Infection-Prone Insertion Site
Devices
 HSMN NewsFeed - 12 Jan 2015
MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2014
Retina Implant AG's International Clinical Results Presented for the First Time in Europe
Devices Ophthalmology
 HSMN NewsFeed - 12 Aug 2014
Cortendo AB: First Patient Enrolled into NormoCort Phase 3 SONICS Trial Following a Successful EU Investigator Meeting
Biopharmaceuticals
 HSMN NewsFeed - 1 Aug 2014
Hill-Rom Completes Acquisition of Trumpf Medical
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2014
Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX(R)) Once-Weekly Prophylaxis For Hemophilia B
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Jun 2014
Integra LifeSciences Celebrates 25th Anniversary
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 May 2014
Pfizer Sends Letter to Rt Hon David Cameron MP Regarding Commitments If Proposed Combination with AstraZeneca is Completed
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 May 2014
Pfizer Confirms Delivery of Increased Proposal to AstraZeneca
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 May 2014
Rotation Medical Appoints Michael J. McNulty Vice President of Sales and Marketing
Devices Orthopaedic Personnel
 HSMN NewsFeed - 1 May 2014
BOTOX(R) (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Apr 2014
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 15 Apr 2014
Reverse Medical(R) Corporation Announces FDA IDE Approval for the BARREL(R) Vascular Reconstruction Device for the Treatment of Intracranial Bifurcation Aneurysms
Devices Interventional Neurosurgery FDA
 HSMN NewsFeed - 14 Apr 2014
Medicrea Announces European Launch of UNiD, the World’s First Patient-Specific Spinal Rod
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 27 Mar 2014
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2014
Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN(R) In Very Young Children Born Small For Gestational Age
Biopharmaceuticals
 HSMN NewsFeed - 21 Mar 2014
 Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT(R) (vintafolide) and Companion Imaging Agents FOLCEPRI(R) (etarfolatide) and NEOCEPRI(R) (Intravenous (IV) folic acid) in Patients with Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology Radiology Regulatory
 HSMN NewsFeed - 12 Mar 2014
Novimmune Appoints Andrew J. Oakley as CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2014
Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2014
InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Jan 2014
Purdue Pharma L.P. Names Mark Timney President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2014
Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 4 Dec 2013
The Medicines Company Acquires Rempex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Nov 2013
Sorin Group Announces CE Mark Approval and First Implant of KORA 100, a New MRI Compatible Pacing System
Devices Cardiology Regulatory
 HSMN NewsFeed - 8 Nov 2013
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2013
Stem Cell Therapeutics Receives U.S. Orphan Drug Designation for the Use of Tigecycline to Treat Acute Myeloid Leukemia
Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 30 Oct 2013
Teva Announces Departure of President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2013
Lorus Therapeutics Appoints New Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Oct 2013
Integra LifeSciences Announces Update on Optimization Initiatives
Devices Neurosurgery
 HSMN NewsFeed - 17 Oct 2013
Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Oct 2013
Misonix Showcases Ultrasonic BoneScalpel(TM) at the Annual Meeting of the North American Spine Society
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 15 Oct 2013
Given Imaging Announces New Data That Suggests Increased Role for PillCam(R) SB in Guiding Therapy for Patients With Gastrointestinal Bleeding
Devices Gastroenterology
 HSMN NewsFeed - 15 Oct 2013
Given Imaging Announces New Studies That Affirm PillCam SB as the Gold Standard for Detecting and Diagnosing Small Bowel Diseases
Devices Gastroenterology
 HSMN NewsFeed - 14 Oct 2013
Multiple New Studies Discuss Clinical Benefits of Given Imaging's PillCam(R) COLON at United European Gastroenterology Week
Devices Gastroenterology
 HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Oct 2013
PTC Therapeutics Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2013
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
Devices Oncology
 HSMN NewsFeed - 3 Sep 2013
Encision Announces Death of Chief Executive Officer Fred F. Perner
Devices Surgery Personnel
 HSMN NewsFeed - 3 Sep 2013
Subanalysis of Phase III ARISTOTLE Trial of Eliquis(R) (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Aug 2013
Introducing New Advil(R) Film Coated Tablets – Designed to Stop Pain Before It Gets Worse
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 12 Aug 2013
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2013
Pfizer Provides Update on Global Regulatory Approvals and Launches of XELJANZ(R) (tofacitinib citrate) for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Jul 2013
Retina Implant AG's Alpha IMS Wins CE Mark
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 1 Jul 2013
Covidien Completes Separation of Pharmaceuticals Business
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Jun 2013
Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix(R) Patent
Biopharmaceuticals Litigation
 HSMN NewsFeed - 22 May 2013
Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression
Devices Gastroenterology
 HSMN NewsFeed - 13 May 2013
Use of TYRX Antibacterial Envelope Associated with Extremely Low 90-Day Cardiac Device Infection Rates
Devices Cardiology
 HSMN NewsFeed - 29 Apr 2013
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 25 Mar 2013
XELJANZ(R) (tofacitinib citrate) Approved in Japan for the Treatment of Adults with Rheumatoid Arthritis (RA)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Mar 2013
The Radiosurgery Society(TM) Completes the 2013 Scientific Meeting Focused on Bridging the Gap: Working Together
Devices Oncology
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Feb 2013
Twelve-Month Outcomes of Popliteal Artery Treatment with the Supera(R) Peripheral Stent System Published in JACC Cardiovascular Interventions
Devices Interventional
 HSMN NewsFeed - 4 Feb 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 1 Feb 2013
Pfizer Inc. Issues Statement on Zoetis(TM) IPO
Biopharmaceuticals
 HSMN NewsFeed - 10 Jan 2013
CardioFocus Announces 1,000 HeartLight(R) Cases Performed Worldwide
Devices Cardiology
 HSMN NewsFeed - 4 Jan 2013
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Jan 2013
Abbott Completes Separation of Research-Based Pharmaceuticals Business
Biopharmaceuticals
 HSMN NewsFeed - 29 Dec 2012
Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS(R) (apixaban)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Dec 2012
ELIQUIS(R) (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 3 Dec 2012
AliveCor’s Heart Monitor for iPhone Receives FDA Clearance
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 8 Nov 2012
Avinger’s Ocelot System is FDA Cleared
Devices Interventional FDA
 HSMN NewsFeed - 8 Nov 2012
90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
Devices Oncology
 HSMN NewsFeed - 8 Nov 2012
joimax(R), EndoSphere Spine, LLC and the University of Toledo, Ohio, Have Signed a License Agreement on Endoscopic Cage Technologies
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 7 Nov 2012
U.S. Food and Drug Administration Approves Pfizer’s XELJANZ(R) (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Methotrexate
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Nov 2012
Bausch & Lomb to Acquire Technolas Perfect Vision GmbH
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 1 Nov 2012
Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
Devices Interventional Personnel
 HSMN NewsFeed - 30 Oct 2012
BioNTech AG Appoints Sean Marett as COO (Chief Operating Officer)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2012
Misonix Attends North American Spine Society (NASS) Meeting - Introduces Expanded Product Range
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 23 Oct 2012
Bovie Medical Corporation to Conduct Conference Call on J-Plasma(TM) Technology
Devices Surgery
 HSMN NewsFeed - 22 Oct 2012
Pfizer To Acquire NextWave Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2012
Varian Medical Systems Expands Market Leadership Position at 2012 ASTRO Meeting in Boston
Devices Oncology
 HSMN NewsFeed - 18 Oct 2012
Aerie Pharmaceuticals Appoints Richard J. Rubino as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 17 Oct 2012
SV Life Sciences and Third Rock Ventures Launch Transformative Medical Device Company Cibiem with $10 Million Series A
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 15 Oct 2012
Cheng Ching General Hospital Delivers First TrueBeam STx Radiosurgery Treatments in Taiwan
Devices Oncology
 HSMN NewsFeed - 11 Oct 2012
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
Biopharmaceuticals
 HSMN NewsFeed - 8 Oct 2012
AngioDynamics to Acquire Vortex Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2012
Study Shows NeurOptics Pupillometers Reliably Measure Pupillary Light Reflex, Helping to Predict Survival and Neurological Outcome after Cardiac Arrest
Devices Neurology
 HSMN NewsFeed - 5 Sep 2012
Penumbra, Inc. Receives Shonin Approval for the Penumbra Coil 400(TM) in Japan To Treat Intracranial Aneurysms
Devices Interventional Regulatory
 HSMN NewsFeed - 4 Sep 2012
STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
Devices Ophthalmology Personnel
 HSMN NewsFeed - 23 Aug 2012
St. Jude Medical Announces Death of Board Member Thomas H. Garrett
Devices Personnel
 HSMN NewsFeed - 20 Jul 2012
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2012
Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
Devices Oncology
 HSMN NewsFeed - 9 Jul 2012
CVRx(R) Names Philippe Wanstok Chief Commercial Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 27 Jun 2012
BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2012
Bristol-Myers Squibb and Pfizer Receive Complete Response Letter from U.S. Food and Drug Administration for ELIQUIS(R) (apixaban)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 May 2012
Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2012
IsoRay to Introduce GliaSite and Cesium-131 Mesh to International Audience at World Congress of Brachytherapy
Devices Oncology
 HSMN NewsFeed - 4 May 2012
Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2012
Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 3 May 2012
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Devices Acquisitions
 HSMN NewsFeed - 3 May 2012
Creabilis Appoints Dr Simon Russell as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2012
New Case Study Reviews Fracture Reduction and Stabilization of a L1 Burst Fracture Using Combined Anterior and Posterior Approach
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 2 May 2012
TearScience’s LipiFlow(R) Treatments a Highlight at American Society of Cataract & Refractive Surgery (ASCRS) Congress
Devices Ophthalmology
 HSMN NewsFeed - 1 May 2012
Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO(TM) (taliglucerase alfa) For The Treatment Of Gaucher Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 May 2012
Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Devices Oncology
 HSMN NewsFeed - 26 Apr 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Apr 2012
Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Apr 2012
Pfizer To Divest Nutrition Business To Nestlé
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 17 Apr 2012
Given Imaging Designates Policlinico A. Gemelli, Catholic University in Rome, as First Colon Capsule Endoscopy Center of Excellence
Devices Gastroenterology
 HSMN NewsFeed - 13 Apr 2012
Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
Devices Interventional
 HSMN NewsFeed - 12 Apr 2012
EDAP Installs Ablatherm-HIFU at Dedicated HIFU Clinic in Poland
Devices Oncology
 HSMN NewsFeed - 12 Apr 2012
Varian Medical Systems Holds Workshop in Advanced Radiotherapy Techniques for African Clinicians
Devices Oncology
 HSMN NewsFeed - 28 Mar 2012
Raptor Pharmaceutical Corp. Announces the Appointment of Henk Doude van Troostwijk as General Manager of European Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2012
Largest Comparative Study of Radioembolisation Shows SIR-Spheres Microspheres Significantly Improves Survival for Cancer Patients with Inoperable Liver Tumours
Devices Oncology
 HSMN NewsFeed - 8 Mar 2012
Celgene Completes Acquisition of Avila Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2012
The Lancet Publishes Results from Gentium's Phase III Defibrotide Trial for the Prevention of VOD in Paediatric Patients
Biopharmaceuticals
 HSMN NewsFeed - 22 Feb 2012
Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 22 Feb 2012
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 15 Feb 2012
FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Jan 2012
Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 12 Jan 2012
Donald Fowler Named President of Toshiba America Medical Systems
Devices Personnel
 HSMN NewsFeed - 1 Jan 2012
Teva Announces Management Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2011
Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2011
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (prebabalin) Capsules CV In Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2011
Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World’s Poorest Countries
Biopharmaceuticals
 HSMN NewsFeed - 15 Dec 2011
World's First Curve(TM) Image Guided Surgery System Now Operating in Germany
Devices Surgery Neurosurgery
 HSMN NewsFeed - 12 Dec 2011
Symmetry Medical to Acquire the Surgical Instruments Business of Codman & Shurtleff
Devices Acquisitions
 HSMN NewsFeed - 2 Dec 2011
Pfizer Completes Acquisition of Excaliard
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2011
Pfizer to Acquire Excaliard Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2011
Retina Implant AG Gains Unanimous Scientific Advisory Board Approval To Expand Clinical Trial Across Europe
Devices Ophthalmology
 HSMN NewsFeed - 17 Nov 2011
Pfizer’s Vyndaqel(R) (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Oct 2011
Pfizer Completes Acquisition Of Icagen
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Oct 2011
Pfizer Receives European Approval to Extend Use of Prevenar 13 to Adults 50 Years and Older for the Prevention of Invasive Pneumococcal Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Oct 2011
Safety to the Power of Three: B. Braun Medical Inc. Announces Introcan Safety(R) 3 Closed IV Catheter
Devices FDA
 HSMN NewsFeed - 5 Oct 2011
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery
Devices Surgery Monitoring
 HSMN NewsFeed - 26 Sep 2011
Aesculap, Inc. Acquires Aragon Surgical, Inc.
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2011
Regulatory Approval for Elekta’s Acquisition of Nucletron
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 Sep 2011
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Sep 2011
CSA Medical Appoints Wendelin Maners VP of Emerging Therapies
Devices Personnel
 HSMN NewsFeed - 8 Sep 2011
Pfizer Announces Detailed Pivotal Data for Investigational Compound Tofacitinib in Rheumatoid Arthritis to be Presented at American College of Rheumatology 2011 Annual Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 7 Sep 2011
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
Diagnostics Licensing Oncology
 HSMN NewsFeed - 6 Sep 2011
NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD(R) and ResQPump) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
Devices Cardiology
 HSMN NewsFeed - 1 Sep 2011
Pfizer Extends Tender Offer to Acquire Icagen, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2011
U.S. Food And Drug Administration Approves Pfizer’s XALKORI(R) (crizotinib) As First And Only Therapy Specifically For Patients With Locally Advanced Or Metastatic ALK-Positive Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Aug 2011
Cook Medical Brings Portable Imaging System to Urologists with Launch of endogo(R) HD
Devices Urology
 HSMN NewsFeed - 15 Aug 2011
Pfizer Wins Viagra Patent Trial
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Aug 2011
Researchers Find RapidArc(R) Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
Devices Oncology
 HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 21 Jul 2011
Elorac, Inc. Promotes Christopher Gabanski as Chief Commercial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jul 2011
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2011
Aesculap Implant Systems, LLC Launches Hydrolift Vertebral Body Replacement System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 27 Jun 2011
Arno Therapeutics Names Alexander Zukiwski, M.D., Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2011
Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2011
Penumbra, Inc. Receives Shonin Approval for the Penumbra System(R) in Japan for Use in the Revascularization of Patients with Acute Ischemic Stroke
Devices Interventional Neurosurgery Regulatory
 HSMN NewsFeed - 13 Jun 2011
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 20 May 2011
ELIQUIS(R) (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement
Biopharmaceuticals Surgery Orthopaedic
 HSMN NewsFeed - 17 May 2011
Pfizer Announces Simultaneous Filing Of New Drug Applications For Crizotinib With U.S. Food And Drug Administration And Japanese Ministry Of Health, Labour And Welfare
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 May 2011
Cappella Medical to Share Data Documenting Benefits of Full Ostial Protection at EuroPCR 2011
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2011
First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
Devices Oncology Neurosurgery
 HSMN NewsFeed - 5 May 2011
The European Commission Approves Pfizer’s Revatio(R) (sildenafil) for the Treatment of Pulmonary Arterial Hypertension in Children
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Apr 2011
NeurogesX CEO Anthony DiTonno to Retire by Year End
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2011
Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2011
Threshold Update Since Sudden Death of Its Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2011
Threshold Announces Unexpected Death of Its Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Apr 2011
Henry Schein Acquires Alpha Scientific
Devices Distribution Mergers & Acquisitions
 HSMN NewsFeed - 4 Apr 2011
Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Mar 2011
Aerocrine appoints Dr. Kathleen Rickard as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2011
Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Mar 2011
Eisai Realigns Its U.S. Operations
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2011
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
Biopharmaceuticals
 HSMN NewsFeed - 2 Mar 2011
Retina Implant AG Secures $18 Million in Second Round of Venture Capital Funding
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 1 Mar 2011
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Feb 2011
NewCardio Study Shows CardioBip Detects Recurrent Atrial Fibrillation Earlier and More Reliably than Periodic Holter Monitoring
Devices Cardiology Monitoring
 HSMN NewsFeed - 7 Feb 2011
Pfizer To Acquire Ferrosan’s Consumer Healthcare Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Feb 2011
CareFusion Names Kieran T. Gallahue Chairman and CEO
Devices Personnel
 HSMN NewsFeed - 31 Jan 2011
Dr. Yvonne Greenstreet Joins Pfizer As Senior Vice President And Head Of Medicines Development, Specialty Care Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2011
EraGen Appoints Gregory D. Rodgers Vice President of Manufacturing
Diagnostics Personnel
Return to NewsFeed  

 Additional items found! 348

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 348 additional stories matching:
COLLEAGUE
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.